Ferozsons Laboratories Limited (PSX:FEROZ)
402.22
+0.37 (0.09%)
At close: Sep 26, 2025
Ferozsons Laboratories Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 692.53 | 551.06 | 569.05 | 415.83 | 830.51 | Upgrade |
Short-Term Investments | 1,945 | - | - | - | - | Upgrade |
Trading Asset Securities | - | 496.5 | 544.97 | 2,036 | 1,940 | Upgrade |
Cash & Short-Term Investments | 2,638 | 1,048 | 1,114 | 2,452 | 2,771 | Upgrade |
Cash Growth | 151.78% | -5.96% | -54.57% | -11.51% | 203.81% | Upgrade |
Accounts Receivable | 2,301 | 2,417 | 1,123 | 1,140 | 1,540 | Upgrade |
Other Receivables | 285.31 | 283.81 | 259.9 | 432.11 | 23.37 | Upgrade |
Receivables | 2,587 | 2,700 | 1,383 | 1,572 | 1,563 | Upgrade |
Inventory | 6,806 | 4,978 | 5,196 | 3,260 | 2,107 | Upgrade |
Prepaid Expenses | - | 11.84 | 7.05 | 1.15 | 0.42 | Upgrade |
Other Current Assets | 867.74 | 1,046 | 833 | 468.26 | 629.81 | Upgrade |
Total Current Assets | 12,898 | 9,783 | 8,533 | 7,754 | 7,071 | Upgrade |
Property, Plant & Equipment | 11,557 | 11,828 | 7,975 | 6,113 | 4,792 | Upgrade |
Other Intangible Assets | 27.63 | 41.04 | 1.55 | 1 | 0.64 | Upgrade |
Other Long-Term Assets | 122.21 | 96.98 | 93.92 | 93.92 | 93.92 | Upgrade |
Total Assets | 24,605 | 21,750 | 16,603 | 13,962 | 11,958 | Upgrade |
Accounts Payable | 3,347 | 1,125 | 2,716 | 1,657 | 1,354 | Upgrade |
Accrued Expenses | 92.7 | 897.6 | 539.82 | 611.89 | 615.99 | Upgrade |
Short-Term Debt | 2,248 | 2,743 | 1,261 | 492.52 | - | Upgrade |
Current Portion of Long-Term Debt | 395.74 | 333.07 | 379.88 | 141.69 | 181.53 | Upgrade |
Current Unearned Revenue | 469.33 | 471.27 | 251.96 | 200.95 | 79.89 | Upgrade |
Other Current Liabilities | 99.12 | 514.79 | 343.17 | 282.76 | 287.6 | Upgrade |
Total Current Liabilities | 6,652 | 6,085 | 5,491 | 3,387 | 2,519 | Upgrade |
Long-Term Debt | 1,648 | 1,844 | 1,841 | 1,537 | 957.1 | Upgrade |
Long-Term Unearned Revenue | 351.55 | 476.91 | 531.88 | 331.33 | 174.13 | Upgrade |
Long-Term Deferred Tax Liabilities | 1,487 | 1,524 | 375.36 | 408.64 | 415.23 | Upgrade |
Total Liabilities | 10,138 | 9,929 | 8,240 | 5,664 | 4,066 | Upgrade |
Common Stock | 434.69 | 434.69 | 434.69 | 362.24 | 362.24 | Upgrade |
Retained Earnings | 8,396 | 7,040 | 6,290 | 6,100 | 5,713 | Upgrade |
Comprehensive Income & Other | 3,544 | 3,754 | 1,193 | 1,305 | 1,398 | Upgrade |
Total Common Equity | 12,375 | 11,228 | 7,918 | 7,768 | 7,473 | Upgrade |
Minority Interest | 2,091 | 591.88 | 445.45 | 530.68 | 419.17 | Upgrade |
Shareholders' Equity | 14,467 | 11,820 | 8,364 | 8,298 | 7,892 | Upgrade |
Total Liabilities & Equity | 24,605 | 21,750 | 16,603 | 13,962 | 11,958 | Upgrade |
Total Debt | 4,292 | 4,920 | 3,482 | 2,171 | 1,139 | Upgrade |
Net Cash (Debt) | -1,654 | -3,872 | -2,368 | 280.9 | 1,632 | Upgrade |
Net Cash Growth | - | - | - | -82.79% | 121.28% | Upgrade |
Net Cash Per Share | -38.05 | -89.08 | -54.47 | 6.46 | 37.55 | Upgrade |
Filing Date Shares Outstanding | 43.51 | 43.47 | 43.47 | 43.47 | 43.47 | Upgrade |
Total Common Shares Outstanding | 43.51 | 43.47 | 43.47 | 43.47 | 43.47 | Upgrade |
Working Capital | 6,246 | 3,698 | 3,042 | 4,367 | 4,552 | Upgrade |
Book Value Per Share | 284.42 | 258.31 | 182.16 | 178.70 | 171.92 | Upgrade |
Tangible Book Value | 12,348 | 11,187 | 7,917 | 7,767 | 7,473 | Upgrade |
Tangible Book Value Per Share | 283.79 | 257.36 | 182.12 | 178.67 | 171.91 | Upgrade |
Land | - | 1,691 | 849.15 | 849.15 | 849.15 | Upgrade |
Buildings | - | 2,013 | 1,117 | 1,048 | 1,028 | Upgrade |
Machinery | - | 5,077 | 3,363 | 2,980 | 2,660 | Upgrade |
Construction In Progress | - | 3,708 | 4,160 | 2,337 | 1,011 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.